In the following chart, we are able to follow ... range of $60.0 to $100.0 over the last 30 days. Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients.

Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...

The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...

A company spokesperson said Dexcom plans to resolve the agency's concerns but stated no design changes were made to its ...

He takes over for Teri Lawver, who in October announced her plans to retire as CCO of the continuous glucose monitor (CGM) ...

The general mood among these heavyweight investors is divided, with 12% leaning bullish and 50% bearish. Among these notable ...